GALECTIN THERAPEUTICS INC. Deferred Tax Expense from Stock Options Exercised
GALECTIN THERAPEUTICS INC. (GALT) reported Deferred Tax Expense from Stock Options Exercised of $2.12 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2021-03-31
- GALECTIN THERAPEUTICS INC. deferred tax expense from stock options exercised for fiscal 2020 was $2.12M, a 0.00% change from fiscal 2019.
- GALECTIN THERAPEUTICS INC. deferred tax expense from stock options exercised for fiscal 2019 was $2.12M, a 0.05% decline from fiscal 2018.
- GALECTIN THERAPEUTICS INC. deferred tax expense from stock options exercised for fiscal 2018 was $2.12M, a 50.00% increase from fiscal 2017.
- GALECTIN THERAPEUTICS INC. deferred tax expense from stock options exercised for fiscal 2017 was $1.41M, a 100.00% increase from fiscal 2016.
| Period end | Deferred Tax Expense from Stock Options Exercised 12 month |
|---|---|
| 2020-12-31 | $2.12M 10-K · filed 2021-03-31 |
| 2019-12-31 | $2.12M 10-K · filed 2020-03-16 |
| 2018-12-31 | $2.12M 10-K · filed 2019-03-06 |
| 2017-12-31 | $1.41M 10-K · filed 2018-03-29 |
| 2016-12-31 | $707.00K 10-K · filed 2017-03-28 |
| 2015-12-31 | $707.00K 10-K · filed 2016-03-15 |
| 2014-12-31 | $707.00K 10-K · filed 2015-03-18 |
| 2013-12-31 | $707.00K 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |